Member Info for Lp160606

LTH,

I 100% do not understand all the mechanics of the manufacturing process. However, i trust Cytivia very much do. And so i do not see this process is in anyway holding us back. They identified & aligned with this partner 4 months ago. I do not believe it is manufacturing holding us up. GDR shared a picture of the beads being manufactured in May so i'm not sure there is a restriction here. Equally we've been assured manufacturing is up to speed.. DB in Vox noted we were good to go and walbrook confirmed at a later date.

The process with Beckman where technical approvals are applicable is new. Bears no restriction on our supposed existing capability with Cytivia. So i don't think your point on the intricacies of the manufacturing process is valid.

It is simply approvals (which i appreciate is somewhat out of their control), and sales that are delaying our Rerate. And until they are delivered the SP ain't going nowhere near 150.

I am here for Covid as it is the most lucrative stream of revenue, anything outside of that is bonus. If you didn't invest here before February, i would think you are here primarily here for Covid also. And stating anything else is merely a smokescreen to gain weight to your posts.

Certainly. But that was pretty easy to deduce considering they released the software amendment 15 minutes after the trading update.

So an oversight from DB & team. Fair assumption?

Production capacity shouldn't be an issue as manufacturing partnership was agreed on May 1st. Snippet from the RNS below

'The PCR-based test has completed its pilot manufacturing runs and yielded high performing multiplexed assays for COVID-19 testing.'

Now I do entirely agree these things take time & of course they want to get everything in line prior to customer engagement. But we are in a very dynamic industry and speed is a key factor.

Outside of the Beckman partnership they've executed on nothing. Luckily, the Beckman opportunity is a cracker, at least at face value. But I'd argue caution in thinking that will provide millions in revenue in the short term. As the RNS states the intial focus is a single site. I do not know the robotic numbers or capacity capability of their site so unsure on potential figures for GDR.

Time will tell and I'm hopeful of some Africa sales soon given social interactions (but that's a loose thing to pin hopes to by my standards)

PP - Facts are facts.

SNG not a fair comparison, treatment deserving of current Mcap considering the efficacy proven in covid patients.. we sell tests. but please post more speculation over the coming weeks.

Yours faithfully.

Pretty easy to rationalise in my view.

BoD shared an expectation of sales at the end of June. It is now the 10th August with 0 paid for tests. And although approvals are no doubt closer than ever, are yet to come in.

No, I completely agree. The opp here has derisked massively due to the partnership in play.

But the validation period is specific to our use case with Beckman, I believe? But we have an FDA approval application already ongoing outside of this.

Perhaps I've misinterpreted, is it your belief that the FDA is linked in with Beckmans validation process?

I'm largely positive on the outlook here now, but I'm still hesitant until I see orders filled, And what our profits per test with Beckman will be.

Aha yes, fair enough.

Overly critical of me.

Onward we March

Not strictly true PP.

Majority thought June, then July, then August.

Not sure it is applicable when the mind changes weekly.

Personal expectation was middle of August.

Not sure we have definitive timelines but would hope both FDA & ICMR will drop this month.

Is it fair to say general consensus is FDA will come prior to ICMR? now our US partnership is formalized I'd expect Beckman to apply pressure to get things moving.

While we have a lull in volume and activity.

Longtermholder, What is it exactly Boris & co have currently got done?

It appears very much a mess from the outside.

Kier starmer is stern opposition. Strongly believe he will oust boris. Simply because he is utterly useless.

How the population seem to of glazed over our death numbers.. beyond me.

Technik, the gov have purchased unproven tests or ppe a number of times now... all seem to have a member of the ruling party affiliated with or sat on the board.

It is a disgrace but one none of us can do anything about. Very frustrating.

The level of corruption and greed at a time like this Is scary.

Nice.

Fyi laboratory technical officer @ Nigeria centre for disease control has like their linkedin post.

So have interactions with a clinical buyer from Tunisia and a lab technician from Nigeria in the past few weeks.

I know it's only interactions but good to see.

Problem is Longrun, those sames Rampers were hitting the sell button while telling the rest to buy the dips.

@Safy just catching up, and some brilliant posts by yourself. My thanks to you in putting this together and sharing it with us.

Very much appreciated.

lol not even remotely comparable. Not even close.

Synairgen announcing their solution will save many lives.

GDR (after having the ability to sell for 3 months) announces a partnership in the states

Not remotely comparable. Move on.

I think he was being sarcastic, at least that is how i interpreted it.

What do you mean?

Weve had the ability to sell the product since the end of May. It is August now, 0 sales. 0 approvals outside of CE.

I think this partnership will prove lucrative, but it's in its infancy still. And is centered on a single site, please read the RNS, it will be no doubt rolled out upon its success. But the reality is with 6 weeks until authorization and a further month for a trial, GDR wont see huge numbers for 3 months, from this deal.

Let's hope India comes in soon. & some African sales are on the way.

NCYT having a solid start. Only one that has commercialised so makes sense..

Normal service resumed then.

Wouldn't hold your breath mate.

Very rare for US investors to pile in. Given we aren't listed Stateside & Beckmann unlikely to release an RNS just yet, i'd be surprised if we increase in volume too much from here.

Either way, good to get an update where we can deduce their GTM.

Long way to go.